Cadila acquires Italian vaccine research company Etna Biotech
November 11th, 2008 - 5:08 pm ICT by IANSAhmedabad, Nov 11 (IANS) Leading Indian healthcare major Zydus Cadila said in a regulatory statement here Tusday that it has acquired Italy-based Etna Biotech, a wholly owned subsidiary of the Dutch biopharma company, Crucell N.VThe financial details of the deal were not disclosed.
Headquartered in Catania, Italy, Etna Biotech focuses on research and development of vaccines, the statement said.
“As an integrated player in the field of healthcare, we have always been exploring opportunities that can take us to the next level of excellence,” Zydus Cadila’s chairman and managing director Pankaj R. Patel said in the statement.
“With this acquisition we will be at the forefront of innovation for vaccine research and development,” the statement said quoting Patel.
Crucell, which was focused on biologicals, entered the vaccine space with the acquisition of Berna Biotech, a globally renowned, specialized vaccine company. Etna was the dedicated research and development wing of Berna Biotech.
Zydus Cadila is an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products. The group’s operations range from active pharmaceutical ingredients (API) to formulations, animal health care products and cosmeceuticals.
Headquartered here, the group has global operations in four continents spread across the US, Europe, Japan, Brazil, South Africa and 25 other emerging markets.
The company employs more than 9,500 people worldwide and reported consolidated revenues of Rs.23.6 billion ($590 million) in the year ended Mar 31, 2008.
- Zydus Cadila buys out Biochem - Dec 21, 2011
- India's Bharat Biotech to sell $1 diarrhoea vaccine - Jun 06, 2011
- Swine flu vaccine yet to hit Delhi markets - Jun 06, 2010
- India-made H1N1 vaccine launched (Lead) - Jun 03, 2010
- India to unveil second swine flu vaccine - Jul 09, 2010
- US trade group sends life sciences mission to India - Jan 31, 2012
- Bharat Biotech vaccine doses touch one-billion mark - Feb 03, 2010
- Issues affecting Indian biopharma industry discussed - Jun 10, 2011
- Study says developing nations biotech firms may be forced to make drugs for rich West - Sep 14, 2010
- Hospira eyeing Indian partners to make medical devices - Dec 17, 2009
- Pune firm slashes pentavalent vaccine prices 60 percent - Jun 13, 2011
- India, Sweden to collaborate in health sector - Feb 20, 2012
- Ranbaxy, Russian region sign healthcare pact - Jan 31, 2011
- Bangalore to host 10th edition of biotech expo June 2 - May 25, 2010
- Zydus Cadila acquires South African firm - Jun 09, 2008
Tags: active pharmaceutical ingredients, animal health care, catania italy, four continents, global pharmaceutical company, health care products, indian healthcare, vaccine company, vaccine research and development, zydus cadila